demonstrated KRS is cleaved by caspase‐8 within cancer cells to facilitate its release via exosomes and, since KRS release from cancer cells is known to affect the inflammatory response, this modulation is relevant in the building of a niche with the potential to promote cancer cell survival and proliferation [44, 168, 183]. The gene discussed is KARS1; the disease is cancer.